Page 196 - 2019_08-Haematologica-web

1688
haematologica | 2019; 104(8)
G. Battipaglia et al. References
1. Spellberg B, Guidos R, Gilbert D, et al. The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America. Clin Infect Dis. 2008;46(2):155-164.
Rapid emergence of secondary resistance togentamicin and colistin following selective digestive decontamination in patients with KPC-2- producing Klebsiella pneumoniae: A single-centre experience. Int J Antimicrob Agents. 2013;42(6):565-570.
11. Rossen NG, MacDonald JK, De Vries EM, et al. Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review. World J Gastroenterol. 2015;21(17):5359- 5371.
12. Manges AR, Steiner TS, Wright AJ. Fecal microbiota transplantation for the intestinal decolonization of extensively antimicrobial- resistant opportunistic pathogens: A review. Infect Dis (Lond). 2016;48(8):587-592.
13. Stalenhoef JE, Terveer EM, Knetsch CW, et al. Fecal microbiota transfer for multidrug- resistant gram-negatives: A clinical success combined with microbiological failure. Open Forum Infect Dis. 2017;4(2):2-5.
14. Bilinski J, Grzesiowski P, Muszynski J, et al. Fecal microbiota transplantation inhibits multidrug-resistant gut pathogens: prelimi- nary report performed in an immunocom- promised host. Arch Immunol Ther Exp (Warsz). 2016;64(3):255-258.
15. de Castro CG Jr, Ganc AJ, Ganc RL, Petrolli MS, Hamerschlack N. Fecal microbiota transplant after hematopoietic SCT: report of a successful case. Bone Marrow Transplant. 2014;50(1):145.
16. Kelly CR, Ihunnah C, Fischer M, et al. Fecal Microbiota Transplant for Treatment of Clostridium diffi cile Infection in Immunocompromised Patients. Am J Gastroenterol. 2014;109(7):1065-1071.
17. Bilinski J, Grzesiowski P, Sorensen N, et al. Fecal microbiota transplantation in patients with blood disorders inhibits gut coloniza- tion with antibiotic-resistant bacteria: results of a prospective, single-center study. Clin Infect Dis. 2017; 65(3):364-370.
18. Magiorakos A, Srinivasan A, Carey RB, et al. bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2011;18(3):268- 281.
19. WHO. Antimicrobial resistance. Global Report on Surveillance. Bull World Health Organ. 2014;61(3):383-394.
20. Schaik W Van. The human gut resistome.
Philos Trans R Soc Lond B Biol Sci.
2015;370(1670):20140087.
21. Taur Y, Jenq RR, Perales M, et al. The effects
of intestinal tract bacterial diversity on mor- tality following allogeneic hematopoietic stem cell transplantation. Blood. 2017;124 (7):1174-1183.
22. Jenq RR, Taur Y, Devlin SM, et al. Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2015;21(8):1373-1383.
23. Austin M, Mellow M, Tierney WM. Fecal microbiota transplantation in the treatment of clostridium difficile infections. Am J Med. 2014;127(6):479-483.
24. Webb BJ, Brunner A, Ford CD, Gazdik MA, Petersen FB. Fecal microbiota transplanta- tion for recurrent Clostridium difficile infec- tion in hematopoietic stem cell transplant recipients.Transpl Infect Dis. 2016;18(4): 628-633.
25. Defilipp Z, Peled JU, Li S, et al. Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversi- ty. Blood Adv. 2018;2(7):745-753.
26. Tang G, Yin W, Liu W. Is frozen fecal micro- biota transplantation as effective as fresh fecal microbiota transplantation in patients with recurrent or refractory Clostridium dif- ficile infection: A meta-analysis? Diagn Microbiol Infect Dis. 2017;88(4):322-329.
27. Moss EL, Falconer SB, Tkachenko E, et al. Long-term taxonomic and functional diver- gence from donor bacterial strains following fecal microbiota transplantation in immuno- compromised patients. PLos One. 2017;12 (8):e0182585.
28. Jones JM, Wilson R, Bealmear PM. Mortality and gross pathology of secondary disease in 17 germfree mouse radiation chimeras. Radiat Res. 1971;45(3):577-588.
29. Shono Y, Docampo MD, Peled JU, et al. Increased GVHD-related mortality with broadspectrum antibiotic use after allogene- ic hematopoietic stem cell transplantation in human patients and mice Yusuke. Sci Transl Med. 2016;8(339):1-16.
30. Kakihana K, Fujioka Y, Suda W, et al. Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host dis- ease of the gut. Blood. 2016;128(16):2083- 2088.
2. Montassier E, Gastinne T, Vangay P, et al. Chemotherapy-driven dysbiosis in the intestinal microbiome. Aliment Pharmacol Ther. 2015;42(5):515-528.
3. Samet A, Śledzińska A, Krawczyk B, et al. Leukemia and risk of recurrent Escherichia coli bacteremia: Genotyping implicates E. Coli translocation from the colon to the bloodstream. Eur J Clin Microbiol Infect Dis. 2013;32(11):1393-1400.
4. Bilinski J, Robak K, Peric Z, et al. Impact of Gut Colonization by Antibiotic-Resistant Bacteria on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective, Single-Center Study. Biol Blood Marrow Transplant. 2016; 22(6):1087- 1093.
5. Cattaneo C, Zappasodi P, Mancini V, et al. Emerging resistant bacteria strains in blood- stream infections of acute leukaemia patients: results of a prospective study by the Rete Ematologica Lombarda (Rel). Ann Hematol. 2016;95(12):1955-1963.
6. Birgand G, Leroy C, Nerome S, et al. Costs associated with implementation of a strict policy forcontrolling spread of highly resist- ant microorganisms in France. BMJ Open. 2016;6(1):1-9.
7. Lepelletier D, Berthelot P, Lucet J, et al. French recommendations for the prevention of “emerging extensively drug-resistant bac- teria ” (eXDR). J Hosp Infect. 2015;90(3):186- 195.
8. Bassetti M, Giacobbe DR, Giamarellou H, et al. Management of KPC-producing Klebsiella pneumoniae infections. Clin Microbiol Infect. 2018;24(2):133-144.
9. Tascini C, Sbrana F, Flammini S, et al. Oral gentamicin gut decontamination for preven- tion of KPC-producing Klebsiella pneumoni- ae infections: Relevance of concomitant sys- temic antibiotic therapy. Antimicrob Agents Chemother. 2014; 58(4):1972-1976.
10. Lübbert C, Faucheux S, Becker-Rux D, et al.